• About
  • Reports
  • Data
  • Consulting Services
  • Insights
  • Cart
MDDetails
  • About
  • Reports
  • Data
  • Consulting Services
  • Insights
  • Cart

MDDetails > Downloads

  • Mozobil 2016 report

    FIND ANOTHER REPORT...

    MDDetails

  • Multaq 2016 report

    FIND ANOTHER REPORT...

    MDDetails

  • Myalept 2016 report

    FIND ANOTHER REPORT...

    MDDetails

  • Mycamine 2016 report

    FIND ANOTHER REPORT...

    MDDetails

  • Myobloc 2016 report

    FIND ANOTHER REPORT...

    MDDetails

  • Myrbetriq 2016 report

    FIND ANOTHER REPORT...

    MDDetails

  • Naftin 2016 report

    FIND ANOTHER REPORT...

    MDDetails

  • Naglazyme 2016 report

    FIND ANOTHER REPORT...

    MDDetails

  • Namenda XR 2016 report

    FIND ANOTHER REPORT...

    MDDetails

  • Namzaric 2016 report

    FIND ANOTHER REPORT...

    MDDetails

  • Nascobal 2016 report

    FIND ANOTHER REPORT...

    MDDetails

  • Nasonex 2016 report

    FIND ANOTHER REPORT...

    MDDetails
  • Previous
  • 1
  • ...
  • 331
  • 332
  • 333
  • 334
  • 335
  • ...
  • 463
  • Next

Recent Posts

  • Five Contemporary Drug Launch Phenotypes​ Every Pharma Marketer Should Know
  • Industry-Sponsored Speaking Tracker
  • U.S. Sales Force Estimator
  • Lilly’s endocrinology-centric launch of Trulicity into T2D
  • Target specialty mix in prostate cancer: Urology vs. Oncology

Categories

  • Case Study
  • Launch Benchmarking
  • Opinion Leader Mapping
  • Product Promotion
  • Tool

©[the-year] MDDetails · Built in Boston, MA

  • @MD_Details
  • Contact Us